Peer-influenced content. Sources you trust. No registration required. This is HCN.
Hematology Advisor
The study’s findings suggest that palliative radiotherapy could be a viable option for managing pain in multiple myeloma patients. With a complete response rate of 48% and a partial response rate of 38%, this treatment approach shows promise.
Hematology November 6th 2023
The Ocular Surface
The study provides valuable insights into the effectiveness of various questionnaires used to diagnose ocular neuropathic pain. It highlights the need for further research to determine the most appropriate questionnaire for this purpose.
Ophthalmology October 30th 2023
Medical Professionals Reference (MPR)
The approval of Combogesic IV, backed by data from two phase 3 studies, signifies a major breakthrough in our ongoing efforts to provide effective and safer alternatives to opioids for postoperative pain management.
Hospitalist October 25th 2023
The New England Journal of Medicine
The human monoclonal antibody could be the treatment polymyalgia rheumatica patients experiencing relapses during glucocorticoid tapering have been waiting for.
Internal Medicine October 11th 2023
Hemophilia News Today
This UK study highlights the urgent need for targeted interventions and close monitoring to improve the quality of life for hemophilia patients suffering from ankle arthropathy.
Hematology October 2nd 2023
Clinical Advisor
AI-driven opioid monitoring systems are increasingly influencing medical decisions, but questions about their accuracy and potential bias persist. Learn how these tools could impact your practice and patient care.
Pain Medicine September 28th 2023